Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q2 2019 13F Holders as of 30 Jun 2019

Holder snapshot 6 signals
Share change
+2,510,918
SEC-reported price per share
$22.87
Number of holders
59
Value change
+$54,344,617
Number of buys
45
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,101,565

Security key

984241109

Report period

Q2 2019

Institutions

59

Top holders

10

Ownership snapshot

Top reported holders of YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
59
Shares
10,972,436
Rows available
59
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
44
Q2 2019 holders
59
Holder diff
15
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 value Q2 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .